Requisition ID: 39968 Organization Located on the traditional, ancestral and unceded lands of the xʷməθkʷəy̓əm (Musqueam), Sḵwx̱wú7mesh (Squamish), and səlilwətaɬ (Tsleil-Waututh) Peoples, Vancouver has a commitment to becoming a City of Reconciliation. Vancouver consistently ranks as
Position: Full Time Floor Leader Weekly: 30-39 hours Interview Plan Floor Leader As a Floor Leader, youll play a vital role in supporting the Store Management Team across all areas of the business. This includes everything
Position: Part Time Floor Leader Weekly: 20-29 hours Interview Plan Floor Leader As a Floor Leader, youll play a vital role in supporting the Store Management Team across all areas of the business. This includes everything
Position: Part Time Floor Leader Weekly: 20-29 hours Interview Plan Floor Leader As a Floor Leader, youll play a vital role in supporting the Store Management Team across all areas of the business. This includes everything
Position: Full Time Floor Leader Weekly: 30-39 hours Interview Plan Floor Leader As a Floor Leader, youll play a vital role in supporting the Store Management Team across all areas of the business. This includes everything
Senior Administrator, Sponsored Research Contracts page is loaded Senior Administrator, Sponsored Research Contracts Apply locations UBC Vancouver Campus time type Full time posted on Posted 5 Days Ago job requisition id JR16166 Staff - Union Job
GENERAL SUMMARY The Attending Veterinarian works under the direct guidance of the General Manager. This position provides leadership, along with the oversight and daily management of the veterinary service team. The goal of this department is
White Rock Veterinary Hospital is looking for an RVT to join our amazing team! We are a larger hospital with 4 DVMs and 3 RVTs, and we have been proudly AAHA accredited since 1987! We are
About Alpha-9 Oncology:Alpha-9 Oncology is a clinical-stage biotechnology company developing radiopharmaceuticals that image and treat solid and hematologic malignancies. Alpha-9 has a portfolio of molecules entering clinical trials and a robust pipeline of additional targets for